26 Sep 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Overeenkomst betreffende herkapitalisatie van operationele dochteronderneming door gewaarborgde schuldeisers en liquidatie van beursgenoteerde holdingmaatschappij
|
20101025 Health Services |
Other subject |
26 Sep 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt resultaten H1 2023 aan en geeft een update over de operationele reorganisatie en herkapitalisatie
|
20101025 Health Services |
Other subject |
26 Sep 2023
07:00 CEST |
BIOCARTIS |
Press Release Biocartis Group NV: Agreement regarding recapitalization of operating subsidiaries by secured by secured creditors and wind down of listed holding company
|
20101025 Health Services |
Other subject |
26 Sep 2023
07:00 CEST |
BIOCARTIS |
Press Release Biocartis Group NV: Biocartis announces H1 2023 Results and provides an update on the operational reorganization and recapitalization
|
20101025 Health Services |
Other subject |
21 Sep 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis 2023 half-year results webcast on 26 September 2023
|
20101025 Health Services |
Other subject |
21 Sep 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Webcast 2023 halfjaarresultaten Biocartis op 26 september 2023
|
20101025 Health Services |
Other subject |
28 Aug 2023
07:00 CEST |
BIOCARTIS |
Press Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders
|
20101025 Health Services |
Other subject |
28 Aug 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis stelt nieuwe Medische Adviesraad (MAR) aan van vooraanstaande medische experts
|
20101025 Health Services |
Other subject |
24 Aug 2023
07:00 CEST |
BIOCARTIS |
Press Release Biocartis Group NV: Biocartis Announces 2023 Half-Year Results on 26 September 2023
|
20101025 Health Services |
Other subject |
24 Aug 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt 2023 Halfjaarresultaten aan op 26 september 2023
|
20101025 Health Services |
Other subject |
10 Aug 2023
07:00 CEST |
BIOCARTIS |
Press Release Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ Platform
|
20101025 Health Services |
Other subject |
10 Aug 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis collaboreert met Lilly om biomarkertests op het Idylla™ Platform te onderzoeken voor NSCLC patiënten
|
20101025 Health Services |
Other subject |
18 Jul 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis appoints George Cardoza as new CFO and Head of Service Delivery
|
20101025 Health Services |
Other subject |
18 Jul 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis benoemt George Cardoza als nieuwe CFO en Hoofd Service Delivery
|
20101025 Health Services |
Other subject |
30 Jun 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Other subject |
30 Jun 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Other subject |
20 Jun 2023
17:40 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
|
20101025 Health Services |
Other subject |
20 Jun 2023
17:40 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of transparency notification
|
20101025 Health Services |
Other subject |
15 Jun 2023
17:15 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt geplande operationele reorganisatie en kostenverminderingsprogramma aan
|
20101025 Health Services |
Other subject |
15 Jun 2023
17:15 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis announces planned operational reorganization and cost reduction program
|
20101025 Health Services |
Other subject |
08 Jun 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of transparency notification
|
20101025 Health Services |
Other subject |
08 Jun 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
|
20101025 Health Services |
Other subject |
05 Jun 2023
17:40 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis announces resignation CFO
|
20101025 Health Services |
Other subject |
05 Jun 2023
17:40 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt vertrek CFO aan
|
20101025 Health Services |
Other subject |
12 May 2023
17:40 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Results of the Annual Shareholders’ Meeting held on 12 May 2023
|
20101025 Health Services |
General meeting / Board Meeting |
12 May 2023
17:40 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Resultaten van de Jaarlijkse Algemene Aandeelhoudersvergadering gehouden op 12 mei 2023
|
20101025 Health Services |
General meeting / Board Meeting |
09 May 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test
|
20101025 Health Services |
News contracts |
09 May 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis en HiloProbe gaan samenwerken op darmkankertest
|
20101025 Health Services |
News contracts |
28 Apr 2023
17:40 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Change in Capital |
28 Apr 2023
17:40 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Change in Capital |
20 Apr 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis rapporteert resultaten eerste kwartaal 2023
|
20101025 Health Services |
Commercial results |
20 Apr 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023
|
20101025 Health Services |
Commercial results |
11 Apr 2023
22:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis benoemt Roger Moody als nieuwe CEO
|
20101025 Health Services |
Other subject |
11 Apr 2023
22:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis appoints Roger Moody as new CEO
|
20101025 Health Services |
Other subject |
11 Apr 2023
07:01 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV:Oproeping tot de Gewone Algemene Aandeelhoudersvergadering
|
20101025 Health Services |
Corporate life |
11 Apr 2023
07:01 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Invitation to the Annual Shareholders’ Meeting
|
20101025 Health Services |
Corporate life |
11 Apr 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis Announces Publication of 2022 Annual Report
|
20101025 Health Services |
Corporate life |
11 Apr 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt publicatie 2022 jaarverslag aan
|
20101025 Health Services |
Corporate life |
04 Apr 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla™ platform
|
20101025 Health Services |
Commercial operations |
04 Apr 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis en APIS Assay Technologies tekenen samenwerkingsovereenkomst voor de ontwikkeling en commercialisering van een subtyperingstest voor borstkanker op het Idylla™ platform
|
20101025 Health Services |
Commercial operations |
31 Mar 2023
17:40 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Other subject |
31 Mar 2023
17:40 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Other subject |
29 Mar 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis To Publish 2022 Annual Report on 11 April 2023
|
20101025 Health Services |
Other subject |
29 Mar 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis zal jaarverslag 2022 publiceren op 11 april 2023
|
20101025 Health Services |
Other subject |
03 Mar 2023
17:40 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of transparency notification
|
20101025 Health Services |
Other subject |
03 Mar 2023
17:40 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
|
20101025 Health Services |
Other subject |
02 Mar 2023
07:00 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis maakt de goedkeuring bekend van de 510(k) door de US FDA van de Idylla™ MSI Test
|
20101025 Health Services |
Other subject |
02 Mar 2023
07:00 CET |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test
|
20101025 Health Services |
Other subject |
28 Feb 2023
17:55 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Other subject |
28 Feb 2023
17:55 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Other subject |